183 related articles for article (PubMed ID: 36476259)
21. Comparison of the effect of three different topoisomerase II inhibitors combined with cisplatin in human glioblastoma cells sensitized with double strand break repair inhibitors.
Macieja A; Kopa P; Galita G; Pastwa E; Majsterek I; Poplawski T
Mol Biol Rep; 2019 Aug; 46(4):3625-3636. PubMed ID: 31020489
[TBL] [Abstract][Full Text] [Related]
22. Analysis of chromatid-break-repair detects a homologous recombination to non-homologous end-joining switch with increasing load of DNA double-strand breaks.
Murmann-Konda T; Soni A; Stuschke M; Iliakis G
Mutat Res Genet Toxicol Environ Mutagen; 2021 Jul; 867():503372. PubMed ID: 34266628
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of non-homologous end joining of gamma ray-induced DNA double-strand breaks by cAMP signaling in lung cancer cells.
Noh SE; Juhnn YS
Sci Rep; 2020 Sep; 10(1):14455. PubMed ID: 32879366
[TBL] [Abstract][Full Text] [Related]
24. A DNA repair player, ring finger protein 43, relieves etoposide-induced topoisomerase II poisoning.
Lerksuthirat T; Wikiniyadhanee R; Stitchantrakul W; Chitphuk S; Stansook N; Pipatpanyanugoon N; Jirawatnotai S; Dejsuphong D
Genes Cells; 2020 Nov; 25(11):718-729. PubMed ID: 32939879
[TBL] [Abstract][Full Text] [Related]
25. Quantitative assessment of HR and NHEJ activities via CRISPR/Cas9-induced oligodeoxynucleotide-mediated DSB repair.
Du J; Yin N; Xie T; Zheng Y; Xia N; Shang J; Chen F; Zhang H; Yu J; Liu F
DNA Repair (Amst); 2018 Oct; 70():67-71. PubMed ID: 30212742
[TBL] [Abstract][Full Text] [Related]
26. BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair.
Kong Y; Xu C; Sun X; Sun H; Zhao X; He N; Ji K; Wang Q; Du L; Wang J; Zhang M; Liu Y; Wang Y; Liu Q
Cancer Biol Med; 2021 Dec; 19(8):1150-71. PubMed ID: 34846107
[TBL] [Abstract][Full Text] [Related]
27. BCR/ABL downregulates DNA-PK(CS)-dependent and upregulates backup non-homologous end joining in leukemic cells.
Poplawski T; Blasiak J
Mol Biol Rep; 2010 Jun; 37(5):2309-15. PubMed ID: 19697154
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of non-homologous end joining mitigates paclitaxel resistance resulting from mitotic slippage in non-small cell lung cancer.
Tsuji K; Kikuchi E; Takashima Y; Shoji T; Takahashi H; Ito S; Morinaga D; Kashima M; Maeda M; Kitai H; Kikuchi J; Sakakibara-Konishi J; Konno S
Cell Cycle; 2023 Sep; 22(17):1854-1864. PubMed ID: 37592765
[TBL] [Abstract][Full Text] [Related]
29. Progression of chromosomal damage induced by etoposide in G2 phase in a DNA-PKcs-deficient context.
Palmitelli M; de Campos-Nebel M; González-Cid M
Chromosome Res; 2015 Dec; 23(4):719-32. PubMed ID: 26152239
[TBL] [Abstract][Full Text] [Related]
30. Increased Gene Targeting in Hyper-Recombinogenic LymphoBlastoid Cell Lines Leaves Unchanged DSB Processing by Homologous Recombination.
Mladenov E; Paul-Konietzko K; Mladenova V; Stuschke M; Iliakis G
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012445
[TBL] [Abstract][Full Text] [Related]
31. Roles of nonhomologous end-joining pathways in surviving topoisomerase II-mediated DNA damage.
Malik M; Nitiss KC; Enriquez-Rios V; Nitiss JL
Mol Cancer Ther; 2006 Jun; 5(6):1405-14. PubMed ID: 16818498
[TBL] [Abstract][Full Text] [Related]
32. Differential and common DNA repair pathways for topoisomerase I- and II-targeted drugs in a genetic DT40 repair cell screen panel.
Maede Y; Shimizu H; Fukushima T; Kogame T; Nakamura T; Miki T; Takeda S; Pommier Y; Murai J
Mol Cancer Ther; 2014 Jan; 13(1):214-20. PubMed ID: 24130054
[TBL] [Abstract][Full Text] [Related]
33. The major DNA repair pathway after both proton and carbon-ion radiation is NHEJ, but the HR pathway is more relevant in carbon ions.
Gerelchuluun A; Manabe E; Ishikawa T; Sun L; Itoh K; Sakae T; Suzuki K; Hirayama R; Asaithamby A; Chen DJ; Tsuboi K
Radiat Res; 2015 Mar; 183(3):345-56. PubMed ID: 25738894
[TBL] [Abstract][Full Text] [Related]
34. TRIM29 is required for efficient recruitment of 53BP1 in response to DNA double-strand breaks in vertebrate cells.
Wikiniyadhanee R; Lerksuthirat T; Stitchantrakul W; Chitphuk S; Sura T; Dejsuphong D
FEBS Open Bio; 2020 Oct; 10(10):2055-2071. PubMed ID: 33017104
[TBL] [Abstract][Full Text] [Related]
35. PHF23 promotes NSCLC proliferation, metastasis, and chemoresistance via stabilization of ACTN4 and activation of the ERK pathway.
Cheng M; Cao H; Yao P; Guan J; Wu P; Ji H; Jiang S; Yuan Y; Fu L; Zheng Q; Li Q
Cell Death Dis; 2023 Aug; 14(8):558. PubMed ID: 37626047
[TBL] [Abstract][Full Text] [Related]
36. ZMYM2 restricts 53BP1 at DNA double-strand breaks to favor BRCA1 loading and homologous recombination.
Lee D; Apelt K; Lee SO; Chan HR; Luijsterburg MS; Leung JWC; Miller KM
Nucleic Acids Res; 2022 Apr; 50(7):3922-3943. PubMed ID: 35253893
[TBL] [Abstract][Full Text] [Related]
37. Genistein-induced DNA damage is repaired by nonhomologous end joining and homologous recombination in TK6 cells.
Hu X; Wu X; Liu H; Cheng Z; Zhao Z; Xiang C; Feng X; Takeda S; Qing Y
J Cell Physiol; 2019 Mar; 234(3):2683-2692. PubMed ID: 30070703
[TBL] [Abstract][Full Text] [Related]
38. Assembly of nuclear matrix-bound protein complexes involved in non-homologous end joining is induced by inhibition of DNA topoisomerase II.
Kantidze OL; Iarovaia OV; Razin SV
J Cell Physiol; 2006 Jun; 207(3):660-7. PubMed ID: 16447266
[TBL] [Abstract][Full Text] [Related]
39. Depletion of tyrosyl DNA phosphodiesterase 2 activity enhances etoposide-mediated double-strand break formation and cell killing.
Kont YS; Dutta A; Mallisetty A; Mathew J; Minas T; Kraus C; Dhopeshwarkar P; Kallakury B; Mitra S; Üren A; Adhikari S
DNA Repair (Amst); 2016 Jul; 43():38-47. PubMed ID: 27235629
[TBL] [Abstract][Full Text] [Related]
40. DNA-PK Inhibition by NU7441 Enhances Chemosensitivity to Topoisomerase Inhibitor in Non-Small Cell Lung Carcinoma Cells by Blocking DNA Damage Repair.
Yanai M; Makino H; Ping B; Takeda K; Tanaka N; Sakamoto T; Yamaguchi K; Kodani M; Yamasaki A; Igishi T; Shimizu E
Yonago Acta Med; 2017 Mar; 60(1):9-15. PubMed ID: 28331416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]